Qube Research & Technologies »

Altimmune shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $465k 179k 2.60
2023-06-30 $3.2M 910k 3.53
2023-03-31 $2.9M 683k 4.22
2022-12-31 $208k 13k 16.45
2022-09-30 $442k 35k 12.78
2021-03-31 $249k 18k 14.11
2020-12-31 $839k 74k 11.28
2020-09-30 $197k 15k 13.23

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Visa Com Cl A Call Option (V)
Meta Platforms Cl A Call Option (META)
Adobe Systems Incorporated Call Option (ADBE)
McDonald's Corporation Call Option (MCD)
NVIDIA Corporation Call Option (NVDA)
salesforce Call Option (CRM)
Netflix Call Option (NFLX)
Johnson & Johnson Put Option (JNJ)
Cisco Systems Put Option (CSCO)
Bank of America Corporation Call Option (BAC)

View all positions for Qube Research & Technologies

Top funds holding Altimmune

Vanguard Group
Tang Capital Management
Point72 Asset Management
Jane Street
Citadel Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Fred Alger Management
Kennedy Capital Management
Beirne Wealth Consulting Services
Wolverine Trading
D. E. Shaw & Co
Gerber
Dimensional Fund Advisors
GSA Capital Partners

View all funds holding Altimmune